Published in Genomics and Genetics Weekly, January 18th, 2008
The ProteOn XPR36 system's unique ability to independently monitor multiple cellular molecular interactions aids in drug development efforts, offering researchers a better understanding of the biological mechanisms that maintain normal cellular processes as well as those that contribute to disease development and the progression of disease.
"Bio-Rad recognized the need for an economical method to conduct...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.